The downside of VC funding for biotech
World of DTC Marketing
JANUARY 24, 2022
Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? VCs invest money in biotech because they see a potential windfall via a profitable acquisition or sale, but when the FDA weighs in with delays, VCs can be ruthless. not necessarily.
Let's personalize your content